药师参与慢性阻塞性肺疾病临床路径的临床效果
|
摘要
目的探讨药师参与慢性阻塞性肺疾病(COPD)临床路径的临床效果。方法选取临沂市精神卫生中心2015年1—3月与2016年1—3月收治的COPD患者84例,随机分为对照组和观察组,各42例。对照组患者实施规范化、标准化临床路径,观察组患者在对照组基础上实施临床药师参与临床路径。比较两组患者住院时间、住院费用、抗菌药物使用时间、抗菌药物用药强度、药物治疗费用及药占比。结果两组患者住院时间及抗菌药物使用时间比较,差异无统计学意义(P>0.05);观察组患者住院费用、药物治疗费用及药占比低于对照组,抗菌药物用药强度低于对照组(P<0.05)。结论药师参与临床路径可进一步完善临床路径,更好地为患者提供用药指导,从而减少治疗费用,缩短治疗时间。
Objective To investigate the application effect of pharmacists participating in clinical pathway implementation of chronic obstructive pulmonary disease(COPD).Methods A total of 84 cases of COPD patients were selected from January to March 2015 and January to March 2016 in Linyi Mental Health Center,which were divided into control group and observation group,42 cases in each group.The control group was given conventional standardized clinical pathway,observation group was given clinical pharmacists intervention based on control group.The hospitalization time,hospitalization expenses,the use time of antibacterial drugs,drug use intensity of antibacterial drugs,drug treatment costs and drug fees accounted were compared between the two groups.Results No significant differences of hospitalization time or the use time of antibacterial drugs was found between the two groups(P>0.05);the observation group of hospitalization expenses,drug treatment costs and drug fees accounted were lower than control group,drug use intensity of antibacterial drugs was less than control group(P<0.05).Conclusion The introduction of pharmacists in clinical pathway can make the clinical pathway more perfect,and provide better medication guidance for patients,so as to reduce the cost of treatment and shorten the treatment time.
Objective To investigate the application effect of pharmacists participating in clinical pathway implementation of chronic obstructive pulmonary disease(COPD).Methods A total of 84 cases of COPD patients were selected from January to March 2015 and January to March 2016 in Linyi Mental Health Center,which were divided into control group and observation group,42 cases in each group.The control group was given conventional standardized clinical pathway,observation group was given clinical pharmacists intervention based on control group.The hospitalization time,hospitalization expenses,the use time of antibacterial drugs,drug use intensity of antibacterial drugs,drug treatment costs and drug fees accounted were compared between the two groups.Results No significant differences of hospitalization time or the use time of antibacterial drugs was found between the two groups(P>0.05);the observation group of hospitalization expenses,drug treatment costs and drug fees accounted were lower than control group,drug use intensity of antibacterial drugs was less than control group(P<0.05).Conclusion The introduction of pharmacists in clinical pathway can make the clinical pathway more perfect,and provide better medication guidance for patients,so as to reduce the cost of treatment and shorten the treatment time.
引文
[1]胡佳莉,苗苗,刘俊.临床药师参与慢性阻塞性肺疾病合并糖尿病的抗感染治疗及药学监护[J].中国医院用药评价与分析,2016,16(4):563-565.
[2]张志清,屠文莲,曹玮.临床药师参与慢性阻塞性肺疾病老年患者抗感染及免疫调节治疗的药学监护[J].中国医院用药评价与分析,2016,16(3):428-430.
[3]鲍光植,田璐璐,周陶然,等.临床药师参与1例AECOPD合并肺部感染患者的治疗实践[J].中国药房,2015,26(32):4584-4586.
[4]黄彧.1例慢性阻塞性肺疾病急性加重期患者临床治疗的药学监护[J].抗感染药学,2015,12(3):349-350.
[5]慢性阻塞性肺疾病(COPD)诊治专家组.慢性阻塞性肺疾病诊治中国专家共识年(2014年修订版)[J].国际呼吸杂志,2014,34(1):1-11.
[6]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.
[7]许懿,谢继青,牟燕,等.临床药师参与治疗1例高血压伴慢性阻塞性肺疾病患者服用比索洛尔致哮喘加重的病例分析[J].中国药房,2013,24(10):953-955.
[8]韦炳华,唐蕾,邓斌,等.慢性阻塞性肺疾病住院患者抗菌药物治疗的对比分析[J].中国药房,2014,25(34):3172-3174.
[9]严郁,徐珽,蒋学华.药师开展药学服务与老年慢性阻塞性肺疾病患者依从性和满意度的相关性研究[J].中国药业,2014,23(14):74-76.
[10]骆松梅,叶伟红,华俊彦.临床药师参与慢性阻塞性肺病急性加重期患者治疗的实践[J].中国临床药理学与治疗学,2013,18(9):1014-1018.
[2]张志清,屠文莲,曹玮.临床药师参与慢性阻塞性肺疾病老年患者抗感染及免疫调节治疗的药学监护[J].中国医院用药评价与分析,2016,16(3):428-430.
[3]鲍光植,田璐璐,周陶然,等.临床药师参与1例AECOPD合并肺部感染患者的治疗实践[J].中国药房,2015,26(32):4584-4586.
[4]黄彧.1例慢性阻塞性肺疾病急性加重期患者临床治疗的药学监护[J].抗感染药学,2015,12(3):349-350.
[5]慢性阻塞性肺疾病(COPD)诊治专家组.慢性阻塞性肺疾病诊治中国专家共识年(2014年修订版)[J].国际呼吸杂志,2014,34(1):1-11.
[6]中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264.
[7]许懿,谢继青,牟燕,等.临床药师参与治疗1例高血压伴慢性阻塞性肺疾病患者服用比索洛尔致哮喘加重的病例分析[J].中国药房,2013,24(10):953-955.
[8]韦炳华,唐蕾,邓斌,等.慢性阻塞性肺疾病住院患者抗菌药物治疗的对比分析[J].中国药房,2014,25(34):3172-3174.
[9]严郁,徐珽,蒋学华.药师开展药学服务与老年慢性阻塞性肺疾病患者依从性和满意度的相关性研究[J].中国药业,2014,23(14):74-76.
[10]骆松梅,叶伟红,华俊彦.临床药师参与慢性阻塞性肺病急性加重期患者治疗的实践[J].中国临床药理学与治疗学,2013,18(9):1014-1018.